|
|
Volumn 48, Issue 4, 2001, Pages 452-453
|
|
Little benefit from mesalazine taken prophylactically after surgery for Crohn's disease
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
MESALAZINE;
PLACEBO;
ADULT;
AGED;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CROHN DISEASE;
DOUBLE BLIND PROCEDURE;
DRUG EFFICACY;
FEMALE;
HUMAN;
HUMAN CELL;
HUMAN TISSUE;
MAJOR CLINICAL STUDY;
MALE;
META ANALYSIS;
MULTICENTER STUDY;
NOTE;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
RECURRENCE RISK;
RELAPSE;
RISK ASSESSMENT;
SIDE EFFECT;
TREATMENT OUTCOME;
ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL;
CHEMOTHERAPY, ADJUVANT;
CROHN DISEASE;
HUMANS;
MESALAMINE;
RANDOMIZED CONTROLLED TRIALS;
RECURRENCE;
TREATMENT OUTCOME;
|
|
EID: 0035076519
PISSN: 00175749
EISSN: None
Source Type: Journal
DOI: 10.1136/gut.48.4.452 Document Type: Note |
|
Times cited : (7)
|
|
References (1)
|
